Location | Total n = 95 (99 sitesa) | Primary cardiac tumors n = 60 (61 sites) | Metastatic cardiac tumors n = 34 (37 sites) | |||
---|---|---|---|---|---|---|
Surgery Group n = 40 (41 sites) | Non-surgery Group n = 20 (20 sites) | Surgery Group n = 10 (12 sites) | Non-surgery Group n = 24 (25 sites) | |||
Benign tumor n = 31 (31 sites) | Malignant tumor n = 10 (11 sites) | |||||
Left Atrium | 34 (34%) | 22 (71%) | 0 | 5 (25%) | 1 (8%) | 6 (24%) |
Right Atrium | 25 (26%) | 2 (6%) | 8 (73%) | 4 (20%) | 4 (34%) | 7 (28%) |
Left Ventricle | 6 (6%) | 1 (3%) | 0 | 4 (20%) | 0 | 1 (4%) |
Right Ventricle | 7 (7%) | 0 | 2 (18%) | 1 (5%) | 1 (8%) | 3 (12%) |
Aortic Valve | 10 (10%) | 5 (16%) | 0 | 5 (25%) | 0 | 0 |
Mitral Valve | 1 (1%) | 0 | 0 | 1 (5%) | 0 | 0 |
Pulmonary Valve | 1 (1%) | 1 (3%) | 0 | 0 | 0 | 0 |
Inferior vena cava | 6 (6%) | 0 | 0 | 0 | 4 (34%) | 2 (8%) |
Aorta | 4 (4%) | 0 | 0 | 0 | 1 (8%) | 3 (12%) |
Pulmonary Artery | 2 (2%) | 0 | 1 (9%) | 0 | 0 | 1 (4%) |
Pericardium | 3 (3%) | 0 | 0 | 0 | 1 (8%) | 2 (8%) |